$17.15
-0.10[-0.58%]
At close: May 3
$17.15
0[0.00%]
After Hours: 4:00PM EDT
Y-mAbs Therapeutics
(NASDAQ:YMAB)Y-mAbs Therapeutics Stock (NASDAQ:YMAB), Quotes and News Summary
Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
| Open | $17.500 |
| Close | $17.150 |
| Volume / Avg. | 246.023K / 378.739K |
| Day Range | 16.987 - 17.778 |
| 52 Wk Range | 4.600 - 20.900 |
| Market Cap | $752.416M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 0 |
| Short Interest | 6.14% |
| Days to Cover | 6.73 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Y-mAbs Therapeutics (YMAB) stock?
You can purchase shares of Y-mAbs Therapeutics (NASDAQ: YMAB) through any online brokerage.
Who are Y-mAbs Therapeutics's (YMAB) competitors?
Other companies in Y-mAbs Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Cogent Biosciences (NASDAQ:COGT).
What is the target price for Y-mAbs Therapeutics (YMAB) stock?
The latest price target for Y-mAbs Therapeutics (NASDAQ: YMAB) was reported by HC Wainwright & Co. on Wednesday, March 6, 2024. The analyst firm set a price target for 22.00 expecting YMAB to rise to within 12 months (a possible 28.28% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Y-mAbs Therapeutics (YMAB)?
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $17.15 last updated Today at May 3, 2024 at 4:00 PM EDT.
Does Y-mAbs Therapeutics (YMAB) pay a dividend?
There are no upcoming dividends for Y-mAbs Therapeutics.
When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?
Y-mAbs Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
Is Y-mAbs Therapeutics (YMAB) going to split?
There is no upcoming split for Y-mAbs Therapeutics.
What sector and industry does Y-mAbs Therapeutics (YMAB) operate in?
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.